MUTHUSAMY SHANMUGAM

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ANI PHARMACEUTICALS INC

Filing Date Source Excerpt
2022-03-25 Muthusamy Shanmugam, our Head of Research and Development and Chief Operating Officer of New Jersey Operations, does not receive additional compensation for his services as a director.
2023-04-11 Muthusamy Shanmugam does not receive additional compensation for his services as a director.
2024-04-05 Muthusamy Shanmugam, 56, has served as a director and as Head of Research & Development and Chief Operating Officer, Novitium Operations since November 2021. Mr. Shanmugam does not receive additional compensation for his services as a director and thus is not included on this table.

Data sourced from SEC filings. Last updated: 2026-03-05